Amylyx Pharmaceuticals, Inc. (AMLX) Form 10-Q Quarterly Reports
Amylyx Pharmaceuticals, Inc. (AMLX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AMLX
CIK: 1658551
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJoseph Apke
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-416950 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001950047-26-010033 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390510 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390509 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390508 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390506 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390507 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001193125-26-389247 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001193125-26-389246 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001193125-26-389245 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001193125-26-389244 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001193125-26-389243 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-01 | 8-K | 0001193125-26-385331 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380152 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359679 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359678 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359677 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359676 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359675 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-19 | 8-K | 0001193125-26-359418 | View SEC Doc Filr Page |
| 424B5 | 2026-08-20 | — | 424B5 | 0001193125-26-359416 | View SEC Doc Filr Page |
| 424B5 | 2026-08-18 | — | 424B5 | 0001193125-26-355696 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | 8-K | 0001193125-26-354793 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | 8-K | 0001193125-26-354716 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336682 | View SEC Doc Filr Page |